SARS coronavirus vaccine development

Advances in Experimental Medicine and Biology

Volumn 581, Issue , 2006, Pages 553-560

  Baric, Ralph S ^a   Sheahan, Timothy ^a   Deming, Damon ^a   Donaldson, Eric ^a   Yount, Boyd ^a   Sims, Amy C ^a   Roberts, Rhonda S ^a   Frieman, Matthew ^a   Rockx, Barry ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934435047     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-33012-9_101     Document Type: Conference Paper

References (22)

1. R. Baric, B. Yount, L. Lindesmith, et al., Expression and self-assembly of norwalk virus capsid protein from Venezuelan equine encephalitis virus replicons, J. Virol. 76, 3023-3030 (2002).
2. J. Cello, A. V. Paul, and E. Wimmer, Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template, Science 297, 1016-1018 (2002).
3. Chinese SARS Molecular Epidemiology Consortium, Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China, Science 303, 1666-1669 (2004).
4. Y. Guan, B. J. Zheng, Y. Q. He, et al., Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China, Science 302, 276-278 (2003).
5. Y. Han, H. Geng, W. Feng, et al., A follow-up of 69 discharged SARS patients, J. Tradit. Chin. Med. 23, 214-217 (2003).
6. S. Jiang, Y. He, and S. Liu, SARS vaccine development, Emerg. Infect. Dis. 11, 1016-1020 (2005).
7. B. Kan, M. Wang, H. Jing, et al., Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms, J. Virol. 79, 11892-11900 (2005).
8. D. Kobasa, A. Takada, K. Shinva, et al., Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus, Nature 431, 703-707 (2004).
9. K. Kuba, Y. Imai, S. Rao, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury, Nat. Med. 11, 875-879 (2005).
10. S. C. Lai, P. C. Chong, C. T. Yeh, et al., Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of SARS-CoV, J. Biomed. Sci. 12, 1-17 (2005).
11. W. Li, M. Moore, N. Vasilieva, et al., Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature 426, 450-454 (2003).
12. M. A. Marra, S. J. M. Jones, C. R. Astell, et al., The genome sequence of the SARS-associated coronavirus, Science 300, 1399-1404 (2003).
13. D. M. Murasko and J. Jiang, Response of aged mice to primary virus infections, Immunol. Rev. 205, 285-296 (2005).
14. G. Pawelec, A. Akbar, C. Caruso, et al., Human immunosenescence: is it infectious? Immunol. Rev. 205, 257-268 (2005).
15. A. Roberts, C. Paddock, L. Vogel, E. Butler, S. Zaki, and K. Subbarao, Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans, J. Virol. 79, 5833-5838 (2005).
16. P. A. Rota, M. S. Oberste, S. S. Monroe, et al., Characterization of a novel coronavirus associated with severe acute respiratory syndrome, Science 300, 1394-1399 (2003).
17. E. J. Snijder, P. J. Bredenbeek, J. C. Dobe, et al., Unique and conserved features of genome and proteome of SARS-CoV, an early split-off from the coronavirus group 2 lineage, J. Mol. Biol. 331, 991-1004 (2003).
18. J. Sui, W. Li, A. Murakami, et al., Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association, Proc. Natl. Acad. Sci. USA 101, 2536-2541 (2004).
19. R. A. Tripp, L. M. Haynes, D. Moore, et al., Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins, J. Virol. Methods 128, 21-28 (2005).
20. H. Weingarl, M. Czub, S. Chub, et al., Immunization with modified vaccinia virus ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis virus in ferrets, J. Virol. 78, 12672-12676 (2004).
21. Z. Yang, H. Werner, W. Kong, et al., Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses, Proc. Natl. Acad. Sci. USA 102, 797-801 (2005).
22. B. Yount, K. Curtis, E. Fritz, et al., Reverse genetics with a full length infectious cDNA of the severe acute respiratory syndrome coronavirus, Proc. Natl. Acad. Sci. USA 100, 12995-13000 (2003).